Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 133Lung Neoplasms 74Brain Neoplasms 27Small Cell Lung Carcinoma 15Melanoma 13Breast Neoplasms 12Neoplasm Metastasis 11Neoplasms 9Carcinoma, Renal Cell 7Adenocarcinoma of Lung 7Prostatic Neoplasms 6NSCLC 5Urinary Bladder Neoplasms 4Recurrence 3Liver Neoplasms 3Kidney Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Bronchogenic 3Bronchial Neoplasms 3Breast Neoplasms, Male 3Thoracic Neoplasms 2Sarcoma 2Respiratory Tract Neoplasms 2Respiratory Tract Diseases 2Neoplasms by Site 2Mesothelioma 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Squamous Cell 2Carcinoma, Neuroendocrine 2

Interventions

Cisplatin 57Pemetrexed 46pembrolizumab 18Nivolumab 15Carboplatin 15Gemcitabine 14Cyclophosphamide 13Radiotherapy 10Drug Therapy 9atezolizumab 8Platinum 7Ipilimumab 7Doxorubicin 7durvalumab 61,2-diaminocyclohexaneplatinum II citrate 6tremelimumab 5sodium thiosulfate 5Vinorelbine 5Radiotherapy, Intensity-Modulated 5Interleukin-2 5Chemotherapy, Adjuvant 5Cerebral Decortication 5sargramostim 4fludarabine 4defactinib 4aldesleukin 4tumor necrosis factor-alpha, CNGRC fusion protein, human 3cediranib 3Photochemotherapy 3Neoadjuvant Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mesothelioma, Malignant × Radiosurgery × Thoracic × Clear all
NCT03399552 2023-10-23

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
15 enrolled 8 charts
Other solid neoplasmThoracic

Mesothelioma, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡